Table 5.
Odds ratio and 95% confidence intervals for associations between measures of skeletal muscle, intramuscular adipose tissue, subcutaneous adipose tissue, visceral adipose tissue and visceral-to-subcutaneous adipose tissue indexes and risk of treatment toxicity.
| Variables | N | Treatment Toxicity | ||
|---|---|---|---|---|
| OR | 95% CI | p-Value | ||
| Sarcopenia | ||||
| Non-sarcopenic | 44 | Reference | ||
| Sarcopenic | 53 | 2.00 | 0.59 to 7.66 | 0.279 |
| Intramuscular adipose tissue index | ||||
| ≤3.85 | 49 | Reference | ||
| >3.85 | 48 | 0.95 | 0.21 to 4.22 | 0.947 |
| Subcutaneous adipose tissue index | ||||
| ≤55.43 | 49 | Reference | ||
| >55.43 | 48 | 1.23 | 0.28 to 5.48 | 0.782 |
| Visceral adipose tissue index | ||||
| ≤41.90 | 49 | Reference | ||
| >41.90 | 48 | 1.35 | 0.30 to 6.50 | 0.696 |
| Visceral-to-Subcutaneous adipose tissue index | ||||
| ≤0.74 | 48 | Reference | ||
| >0.74 | 49 | 1.57 | 0.44 to 5.95 | 0.490 |
All models were adjusted for age, BMI, cancer type and cancer stage.